TABLE 2.
Criterion (weight) | Description of criterion | Scoring |
---|---|---|
Clinical utility (30%) | This criterion assessed whether the indicator could improve pregnancy health and/or improve long-term health. This criterion was independently assessed by two CDC medical officers. |
|
Included in clinical recommendations (25%) | Determine whether or not the indicator is included in or addressed by professional recommendations. |
|
Data availability (20%) | This criterion assesses the availability of data for the indicator. |
|
Related to a HP2020 objective or NQF measure (10%) | Determine whether or not the indicator is included in or addressed by HP2020 objectives or NQF measures. |
|
Related to the condensed set preconception health indicators (10%) | Inclusion in the condensed set of preconception health indicators was considered to be evidence of relevance and indicators with such evidence received higher scores. |
|
Target population (i.e., proportion of women who need the service) (5%) | State whether the target population that the indicator pertains to is the entire population of the data source or a subset of women for the data source. |
|
Prevalence | Prevalence estimate of the PCC indicator in all available reporting areas. | Unscored |
Simplicity—calculating the indicator | Level of difficulty in calculating estimates of the indicator. | Unscored |
HP, healthy people; NQF, National Quality Forum.